Literature DB >> 4039243

Forskolin suppresses sympathetic neuron function and causes ocular hypotension.

D E Potter, J A Burke, J R Temple.   

Abstract

Recent reports suggest that forskolin can produce ocular hypotension in laboratory animals and man by enhancing formation of cyclic AMP. This proposed mechanism of action implies that forskolin lowers intraocular pressure (IOP) by activating adenylate cyclase at some postjunctional site. Intra-arterial (i.a.) injections of forskolin (10, 33, 100 & 333 micrograms) into the cat nictitating membrane (CNM) preparation produced dose-related inhibition of contractions elicited by electrical stimulation of pre-and postganglionic sympathetic neurons. Interestingly, contractions elicited by i.a. norepinephrine were inhibited less than neuronally mediated contractions. Topically applied forskolin (0.5 mg) to the eyes of unilaterally sympathectomized (SX) rabbits and normal rabbits elicited ocular hypotension in the innervated eyes only. Forskolin (0.5 mg, topically) suppressed the rise in IOP induced by water loading in normal rabbits but was significantly less effective in SX rabbits. These results suggest that forskolin lowered IOP in rabbits and suppressed contraction of the electrically-stimulated CNM, in part, by inhibiting sympathetic neuronal function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039243     DOI: 10.3109/02713688508999973

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Role of cyclic AMP-induced Cl conductance in aqueous humour formation by the dog ciliary epithelium.

Authors:  S Chen; R Inoue; H Inomata; Y Ito
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

2.  Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study.

Authors:  Muhammed Majeed; Kalyanam Nagabhushanam; Sankaran Natarajan; Priti Vaidyanathan; Suresh Kumar Karri; Jyolsna Agnes Jose
Journal:  Saudi J Ophthalmol       Date:  2015-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.